4.4 Article

Association of Body Composition and Handgrip Strength with Interleukin-6 (IL-6) and Vitamin D Level in Cancer Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement

Lorenzo M. Donini et al.

Summary: Loss of skeletal muscle mass and function is common in individuals with obesity. The co-existence of excess adiposity and low muscle mass/function, known as sarcopenic obesity (SO), negatively impacts patient outcomes. However, the lack of a universally established definition and diagnostic criteria for SO hampers prevention and treatment efforts.

OBESITY FACTS (2022)

Review Geriatrics & Gerontology

A systematic review examining the relationship between cytokines and cachexia in incurable cancer

D. Robert Paval et al.

Summary: Cancer cachexia is a clinical need that affects more than 50% of cancer patients. This systematic review examines the relationship between cytokines and cachexia syndrome in patients with incurable cancer. The findings suggest that cytokines, particularly IL-6, TNF-α, and IL-8, are associated with the development of cachexia.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Nutrition & Dietetics

Effects of Vitamin D and K on Interleukin-6 in COVID-19

Margot P. J. Visser et al.

Summary: This study found a significant association between IL-6 levels and poor disease outcomes in COVID-19 patients. The levels of dp-ucMGP, a biomarker of vitamin K status, were correlated with IL-6 levels, while 25-hydroxyvitamin D levels showed only borderline statistical significance in correlation with IL-6 levels.

FRONTIERS IN NUTRITION (2022)

Article Oncology

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Konstantinos Rounis et al.

Summary: The study found that CCS is associated with reduced efficacy of PD-1/PD-L1 inhibitors in NSCLC patients and should be an additional stratification factor in future I-O clinical trials. Further research at a translational and molecular level is needed to elucidate the mechanisms of metabolic deregulation and suppression of antitumor immunity.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Review Nutrition & Dietetics

Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy

Matheus Garcia et al.

NUTRITION (2019)

Article Biochemistry & Molecular Biology

Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning

Jun Han et al.

LIPIDS IN HEALTH AND DISEASE (2018)

Article Medicine, Research & Experimental

White blood cell counts, insulin resistance, vitamin D levels and sarcopenia in Korean elderly men

Sang-Hwan Kim et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)

Article Oncology

Vitamin D and VDR in cancer cachexia and muscle regeneration

Andrea Camperi et al.

ONCOTARGET (2017)

Editorial Material Oncology

IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm

James P. White

TRANSLATIONAL CANCER RESEARCH (2017)

Article Endocrinology & Metabolism

Vitamin D and its role in skeletal muscle

Lisa Ceglia

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)

Review Physiology

Mechanisms of Cancer Cachexia

Michael J. Tisdale

PHYSIOLOGICAL REVIEWS (2009)

Article Physiology

Interleukin-6 and cachexia in ApcMin/+ mice

Kristen A. Baltgalvis et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)